AMGN

Ranking the Top 10 Stock Buybacks of Last Year

By Will Ashworth, InvestorPlace Contributor
The top ten stock buybacks by S&P 500 companies in 2018 totaled $252 billion. Here are the best stocks to buy of the bunch.

5 Top Stock Trades for Thursday: CVS, TWLO, EL, AMGN

By Bret Kenwell, InvestorPlace Contributor
CVS, Twilio, Amgen and Estee Lauder all reported earnings. Alibaba stock is breaking out. Here are our top stock trades to watch now.

Amgen Earnings: AMGN Stock Dips Slightly Despite Q1 EPS, Sales Beat

By Karl Utermohlen, InvestorPlace Writer
Amgen reported its latest quarterly earnings results after hours today, bringing in a profit that topped expectations, yet AMGN stock fell.

3 Big Stock Charts for Thursday: Citrix Systems, Goldman Sachs Group and Amgen

By James Brumley, InvestorPlace Feature Writer
The stock charts of AMGN, CTXS and GS stock are ready to start the last trading day of the week on a trade-worthy foot.

Why Amgen Stock Could Break Out to New Highs

By Bret Kenwell, InvestorPlace Contributor
Amgen shares have a reasonable valuation, 3% dividend yield and a strong-looking chart. Is it time to buy AMGN stock now?

15 Safe Dividend Stocks to Buy for the Rest of 2019

By Josh Enomoto, InvestorPlace Contributor
Given the markets’ many question marks, these safe dividend stocks to buy offer reliable yields and steady growth potential.

10 Risky (But Rewarding) Small-Cap Stocks to Buy Now

By James Brumley, InvestorPlace Feature Writer
These ten stocks aren't exactly household names, but they each deserve a spot in a list of small-cap stocks to buy now for traders that can deal with the risk for the potential of high reward.

Amgen Earnings: AMGN Stock Slips on Q4 Earnings Beat, Weak Q1 Guidance

By Karl Utermohlen, InvestorPlace Writer
Amgen earnings (AMGN) were better than what analysts were calling for after hours, but AMGN stock slid as the its guidance missed the mark.

3 of the Top Big Pharma Stocks to Buy Now

By Chris Lau, InvestorPlace Contributor
Big pharma stocks are getting good coverage from JPMorgan's healthcare event. Here are three undervalued pharmaceutical stocks to buy now.

7 Major Pharmaceutical Stocks to Quarantine Now

By Josh Enomoto, InvestorPlace Contributor
Despite their indispensable demand, pharmaceutical stocks face tough roadblocks as competition for breakthrough drugs intensifies.

10 Stocks to Buy When the Yield Curve Inverts

By James Brumley, InvestorPlace Feature Writer
An inverted yield curve may be around the corner, forcing investors to rethink what they really want to own.

3 Big Stock Charts for Wednesday: Delta Air Lines, Amgen and Mondelez International

By James Brumley, InvestorPlace Feature Writer
The stock charts of AMGN, DAL and MDLZ are put under the spotlight on this week's hump-day. Here's what to watch.

6 Pharmaceutical Stocks to Buy After the Midterms

By Chris Lau, InvestorPlace Contributor
The upside case for pharmaceutical stocks is building. The midterm elections results mean its unlikely drug price regulation will happen soon.

10 Stocks to Buy in November

By James Brumley, InvestorPlace Feature Writer
Verizon, CBS and Amgen are just some of the stocks to buy to get the most out of the usual November and December rally.

Gilead Sciences Stock Is Back to Base — Go Long

By Nicolas Chahine, InvestorPlace Contributor
Gilead stock is cheap selling at 11 price-earnings ratio. And it's coming into a long-term support zone. Catch the falling butter knife.

10 S&P 500 Stocks to Buy for the Long Term

By James Brumley, InvestorPlace Feature Writer
If you want some set-it-and-forget-it holdings for your portfolio, these S&P 500 stocks are ideal stocks to buy.

Will This FDA Approval Affect Amgen Stock Significantly?

By
AMGN stock is still riding on a rocky road despite news of a new FDA approval. Here's what Amgen investors need to know.

5 Breakout Stocks to Buy

By Anthony Mirhaydari, InvestorPlace Market Strategist
These big-name stocks are showing new signs of life, making each an ideal company for your list of stocks to buy.

Trade of the Day: Amgen Is a Strong Stock in a Giddy Industry

By Serge Berger, InvestorPlace Contributor
AMGN stock has seen a steady incline since May and one that has good odds of continuing. This is sponsored by a general bid in the healthcare and biotechnology sectors.
Load More